XOMA Royalty (XOMA) Operating Income (2011 - 2026)

XOMA Royalty's (XOMA) quarterly Operating Income came in at -$480000.0 in Q1 2026, down 108.1% year-on-year from $5.9 million in Q1 2025, and up 80.96% quarter-over-quarter from -$2.5 million in Q4 2025.

XOMA Royalty (XOMA) Operating Income (2011 - 2026) Analysis & Trends

XOMA Royalty has disclosed Operating Income across 16 years of filings, most recently posting -$480000.0 for Q1 2026.

  • Operating Income for Q1 2026 came in at -$480000.0, down 108.1% year-over-year; the trailing twelve-month figure through Mar 2026 was $272000.0 (up 101.01% YoY), and the FY2025 annual result was $6.7 million, up 116.71% from the prior year.
  • Operating Income came in at -$480000.0 for Q1 2026 at XOMA Royalty, up from -$2.5 million in the prior quarter.
  • In the past five years, Operating Income ranged from a high of $5.9 million in Q1 2025 to a low of -$19.9 million in Q4 2023.
  • The 5-year median for Operating Income is -$5.8 million (2023), against an average of -$5.5 million.
  • Across the five-year window, Operating Income plunged 392.49% in 2023 and jumped 184.65% in 2025, its largest moves.
  • XOMA Royalty's Operating Income stood at -$6.2 million in 2022, then slumped by 221.0% to -$19.9 million in 2023, then jumped by 63.61% to -$7.3 million in 2024, then jumped by 65.24% to -$2.5 million in 2025, then surged by 80.96% to -$480000.0 in 2026.
  • The last three Operating Income figures came in at -$480000.0 (Q1 2026), -$2.5 million (Q4 2025), and -$1.3 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Op. Inc (Qtr)
1 Alterity Therapeutics 788,338.31 Bn 788,338.28 Bn - -
2 Belite Bio 56,560.00 Bn 56,560.00 Bn - -32.68 Mn
3 Quantum Biopharma 17,329.30 Bn 17,329.30 Bn - -2.97 Mn
4 Legend Biotech 3,341.00 Bn 3,340.71 Bn 242.10 Mn -19.70 Mn
5 Akari Therapeutics 1,727.91 Bn 1,727.91 Bn - -15.76 Mn
6 Evaxion A 1,536.68 Bn 1,536.67 Bn - -3.82 Mn
7 Psyence Biomedical 238.34 Bn 238.33 Bn - -
8 Vertex Pharmaceuticals 113.42 Bn 106.17 Bn 2.59 Bn 1.14 Bn
9 Abivax 95.45 Bn 95.45 Bn - -65.83 Mn
10 XOMA Royalty 5.52 Mn -60.56 Mn - -480,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 -480,000.00
Dec 31, 2025 -2.52 Mn
Sep 30, 2025 -1.33 Mn
Jun 30, 2025 4.60 Mn
Mar 31, 2025 5.93 Mn
Dec 31, 2024 -7.25 Mn
Sep 30, 2024 -15.64 Mn
Jun 30, 2024 -10.08 Mn
Mar 31, 2024 -7.00 Mn
Dec 31, 2023 -19.93 Mn
Sep 30, 2023 -5.79 Mn
Jun 30, 2023 -5.96 Mn
Mar 31, 2023 -10.17 Mn
Dec 31, 2022 -6.21 Mn
Sep 30, 2022 -4.37 Mn
Jun 30, 2022 -4.77 Mn
Mar 31, 2022 -2.07 Mn
Dec 31, 2021 30.37 Mn
Sep 30, 2021 -3.35 Mn
Jun 30, 2021 -3.06 Mn